Anti-human IgE (Talizumab Biosimilar) Size:5 mg ventricular/cardiac muscle isoform

ventricular/cardiac muscle isoform

Number Component 50T Concentration Storage 1 PBS Buffer (powder) 2L x 2 20x RT 2 Antigen Retrieval Buffer 20ml 100x 2-8°C 3 Endogenous Peroxidase Blocking Buffer 3ml RTU 2-8°C 4 Blocking Buffer 3ml RTU 2-8°C 5 Primary Antibody (Rat GAT1 Recombinant Rabbit mAb) 6ml RTU 2-8°C 6 Secondary Antibody (Goat Anti-Rabbit IgG H&L

medium heat for 8 min

These modifications include the covalent attachment of methyl or acetyl groups to lysine and arginine amino acids and the phosphorylation of serine or threonine

Myosin heavy chain

Anti-human IgE (Talizumab Biosimilar) Size:5 mg ventricular/cardiac muscle isoformApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name IgE Target Uniprot P0DOX4 Overview Catalog# BIO0628SM Product Name Anti human IgE (Talizumab Biosimilar) Specifications Conjugation None Clone# Talizumab Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with sterile ddH2O Concentration Lyophilized